CompletedPhase 1NCT02660281
URMC Related Haplo-identical Donor BMT
Studying Primary bone lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Rochester
- Principal Investigator
- Jeffrey Andolina, MD, PA-CWilmot Cancer Center
- Intervention
- Total Body Irradiation 1200 cGy(radiation)
- Enrollment
- 74 enrolled
- Eligibility
- 75 years · All sexes
- Timeline
- 2015 – 2021
Study locations (1)
- Wilmot Cancer Institute, Rochester, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02660281 on ClinicalTrials.gov